Moreover, we found the protective effects of ACLY inhibitors on vital organ injuries in mice with sepsis, which is supported by recent studies that proposed ACLY inhibition as a potential treatment target for cancer, sepsis, and/or other metabolic diseases [10, 15, 21, 35]. The gene discussed is ACLY; the disease is cancer.